Clinical Trial Update: AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs

View source ↗

Summary

This clinical trial update notes an active-not-recruiting study sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori in Milan evaluating AI-based lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Lung Cancer, Blood Biomarkers | Status: ACTIVE_NOT_RECRUITING